• By ICR Secretariat
  • Posted Thursday, July 8, 2021

Roche partner sees promise for anti-COVID 19 pill in early study

https://www.biopharmadive.com/news/roche-atea-covid-pill-data/602642/

  • An experimental pill under development by Atea Pharmaceuticals and Roche helped curb viral loads in hospitalized patients with coronavirus infections, according to interim results from a Phase 2 trial.